Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 5/24/05  and contains information from public web pages and contributions from the ZoomInfo community.

Mr. John R. Barr

Wrong John R. Barr?
 
Background

Employment History

Board Memberships and Affiliations

Education

  • MBA
    Kellogg School of Management at Northwestern University
  • B.S. , Bioengineering
    University of Pennsylvania
  • Bachelor of Science Degree , bioengineering
    University of Pennsylvania
  • Master’s Degree , management
    J.L. Kellogg Graduate School of Management
171 Total References
Web References
The other two current Class I ...
www.sec.gov, 24 May 2005 [cached]
The other two current Class I Directors, Dr. Richard Charpie and Mr. John Barr, are not standing for re-election to the Board.
...
John R. Barr, age 48, joined our company as President, Chief Executive Officer and a director in November 1997.With the merger with Panacos in March 2005, Mr. Barr remains as President and a director.Previously, Mr. Barr served as President of North American Operations at Haemonetics Corporation from 1995 to 1997 where he had responsibility for Haemonetics' blood bank, commercial plasma and blood bank services businesses.He also managed the global manufacturing and North American research and development functions and served as a member of the Board of Directors of Haemonetics.Prior to joining Haemonetics in 1990, he held various positions at Baxter Healthcare Corporation.Mr. Barr has an undergraduate degree in Biomedical Engineering from the University of Pennsylvania and an M.M. from the Kellogg School of Management at Northwestern University.
...
The Committee was composed of Mr. David Tendler, Mr. John Barr, and Dr. Richard Charpie, with Mr. Tendler, who resigned from our Board in March 2005, serving as Chairman.
...
Mr. Barr is the President of Vitex.Prior to the merger with Panacos in March 2005, Mr. Barr served as Chief Executive Officer of Vitex.
Corporate Governance - List of Executive Leadership Team Members : Bausch + Lomb
www.zyletrex.com, 8 July 2013 [cached]
John Barr Corporate Vice President and President, Global Surgical
...
John Barr is Executive Vice President and Global President of Bausch + Lomb's Surgical business. He was named to this post in May 2012, and reports to Bausch + Lomb's President and CEO, Brent Saunders.
Mr. Barr has extensive medical device and biotechnology industry experience spanning a wide variety of operational, strategy and customer-facing roles in which he consistently increased company value and delivered business results.
At Bausch + Lomb, Mr. Barr has global responsibility for the company's full suite of ophthalmic surgical products, intraocular lenses (IOLs) and delivery systems, which include such brand names as enVista™ Crystalens®, Stellaris® PC, Storz™and VICTUS™.
Immediately prior to joining Bausch + Lomb, Barr was President and CEO of AGA Medical, a pioneer of minimally invasive devices to treat structural heart defects and vascular abnormalities. Under his leadership, AGA Medical, which had been a Welsh Carson Anderson and Stowe-owned portfolio company, completed a successful IPO before ultimately being acquired by St. Jude Medical.
Barr also spent more than eight years at V.I. Technologies, an anti-infective therapeutics company as its President and COO. Prior to joining V. I. Technologies, Barr spent seven years with Haemonetics, a manufacturer of blood processing technology, in a variety of customer service and operations roles before ultimately being named President of North American Operations.
Earlier in his career, Barr spent nearly 10 years at Baxter Healthcare in a number of financial and operational assignments culminating with his being promoted to Vice President of the company's healthcare IT solutions division, which ultimately merged with IBM Hospital Systems.
Barr is a graduate of the J. L. Kellogg Graduate School of Management-Northwestern University in Evanston, IL where he earned his master's degree in Accounting and Economics. He earned his undergraduate degree in Bioengineering from the University of Pennsylvania in Philadelphia, PA. Barr is also a former member of the Board of Directors for AdvaMed.
Management Team
www.surgicalspecialties.com, 14 Nov 2014 [cached]
John R. Barr
Chief Executive Officer
Chief Executive Officer, Mr. John R. Barr, has over 30 years of experience in the medical device industry. Prior to joining Surgical Specialties Corporation, Mr. Barr served as the Executive Vice President and President of Global Surgical at Bausch & Lomb (until the company's 2013 acquisition by Valeant Pharmaceuticals). From 2005 to 2011 Mr. Barr rose from the role of Chief Operating Officer to Chief Executive Officer of AGA Medical Corporation, which went public in 2009. As Chief Executive Officer of V.I. Technologies, from 1997-2005, he led the company's 2008 IPO. Mr. Barr is also a past President and Member of the Board of Directors of Haemonetics Corporation and began his career at Baxter Healthcare Corporation.
Mr. Barr is a graduate of the J. L. Kellogg Graduate School of Management-Northwestern University where he earned his Master's degree in finance, accounting and economics. He earned his undergraduate degree in bioengineering from the University of Pennsylvania.
AGA Medical Corporation - Investors - Corporate Governance - Management
phx.corporate-ir.net, 18 Nov 2010 [cached]
John R. Barr President and Chief Executive Officer
...
John R. Barr President and Chief Executive Officer
John R. Barr has served as the President and Chief Executive Officer since June 2008 and, prior to that served as the Chief Operating Officer since September 2005. Prior to joining the company, Mr. Barr served as President and Chief Executive Officer of V.I. Technologies prior to its merger with Panacos Pharmaceuticals in 2005. Prior to joining V.I. Technologies, Mr. Barr served from June 1990 to November 1997 as President of North American Operations for Haemonetics Corporation, a leading medi... 
Dr. Ackerman continued, "On behalf of ...
www.COOLEYNET.COM, 11 Mar 2005 [cached]
Dr. Ackerman continued, "On behalf of the Vitex Board, I would also like to thank John Barr for his outstanding leadership during the merger process."
...
Mr. Barr, President of Vitex, commented, "The merger with Panacos represents a major step for Vitex toward becoming a leader in development of anti-infective therapeutic products.
Other People with the name "Barr":
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.